Literature DB >> 18314967

Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease.

Yanfeng Chen1, Jeremy Allegood, Ying Liu, Elaine Wang, Begoña Cachón-Gonzalez, Timothy M Cox, Alfred H Merrill, M Cameron Sullards.   

Abstract

The quality of tissue imaging by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) depends on the effectiveness of the matrix deposition, especially for lipids that may dissolve in the solvent used for the matrix application. This article describes the use of an oscillating capillary nebulizer (OCN) to spray small droplets of matrix aerosol onto the sample surface for improved matrix homogeneity, reduced crystal size, and controlled solvent effects. This system was then applied to the analysis of histological slices of brains from mice with homozygous disruption of the hexb gene (hexb-/-), a model of Tay-Sachs and Sandhoff disease, versus the functionally normal heterozygote (hexb+/-) by imaging MALDI-MS. This allowed profiling and localization of many different lipid species, and of particular interest, ganglioside GM2, asialo-GM2 (GA2), and sulfatides (ST). The presence of these compounds was confirmed by analysis of brain extracts using electrospray ionization in conjunction with tandem mass spectrometry (MS/MS). The major fatty acid of the ceramide backbone of both GM2 and GA2 was identified as stearic acid (18:0) versus nervonic acid (24:1) for ST by both tissue-imaging MS and ESI-MS/MS. GM2 and GA2 were highly elevated in hexb-/- and were both localized in the granular cell region of the cerebellum. ST, however, was localized mainly in myelinated fiber (white matter) region of the cerebellum as well as in the brain stem with a relatively uniform distribution and had similar relative signal intensity for both hexb+/- and hexb-/- brain. It was also observed that there were distinct localizations for numerous other lipid subclasses; hence, imaging MALDI-MS could be used for "lipidomic" studies. These results illustrate the usefulness of tissue-imaging MALDI-MS with matrix deposition by OCN for histologic comparison of lipids in tissues such as brains from this mouse model of Tay-Sachs and Sandhoff disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18314967     DOI: 10.1021/ac702350g

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  55 in total

1.  MALDI imaging of lipid biochemistry in tissues by mass spectrometry.

Authors:  Karin A Zemski Berry; Joseph A Hankin; Robert M Barkley; Jeffrey M Spraggins; Richard M Caprioli; Robert C Murphy
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 3.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Molecular mass spectrometry imaging in biomedical and life science research.

Authors:  Jaroslav Pól; Martin Strohalm; Vladimír Havlíček; Michael Volný
Journal:  Histochem Cell Biol       Date:  2010-10-28       Impact factor: 4.304

5.  Imaging of phospholipids in formalin fixed rat brain sections by matrix assisted laser desorption/ionization mass spectrometry.

Authors:  Claire L Carter; Cameron W McLeod; Josephine Bunch
Journal:  J Am Soc Mass Spectrom       Date:  2011-09-01       Impact factor: 3.109

6.  MALDI mass spectrometric imaging of lipids in rat brain injury models.

Authors:  Joseph A Hankin; Santiago E Farias; Robert M Barkley; Kim Heidenreich; Lauren C Frey; Kei Hamazaki; Hee-Yong Kim; Robert C Murphy
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-09       Impact factor: 3.109

Review 7.  MALDI imaging mass spectrometry: state of the art technology in clinical proteomics.

Authors:  Julien Franck; Karim Arafah; Mohamed Elayed; David Bonnel; Daniele Vergara; Amélie Jacquet; Denis Vinatier; Maxence Wisztorski; Robert Day; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2009-05-18       Impact factor: 5.911

Review 8.  Mass spectrometry imaging, an emerging technology in neuropsychopharmacology.

Authors:  Mohammadreza Shariatgorji; Per Svenningsson; Per E Andrén
Journal:  Neuropsychopharmacology       Date:  2013-08-21       Impact factor: 7.853

9.  Detection of carbohydrates and steroids by cation-enhanced nanostructure-initiator mass spectrometry (NIMS) for biofluid analysis and tissue imaging.

Authors:  Gary J Patti; Hin-Koon Woo; Oscar Yanes; Leah Shriver; Diane Thomas; Wilasinee Uritboonthai; Junefredo V Apon; Rick Steenwyk; Marianne Manchester; Gary Siuzdak
Journal:  Anal Chem       Date:  2010-01-01       Impact factor: 6.986

Review 10.  Gangliosides in cell recognition and membrane protein regulation.

Authors:  Pablo H H Lopez; Ronald L Schnaar
Journal:  Curr Opin Struct Biol       Date:  2009-07-14       Impact factor: 6.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.